Preclinical neurophysiological and behavioral assays of motivation and effort

动机和努力的临床前神经生理学和行为分析

基本信息

  • 批准号:
    10439637
  • 负责人:
  • 金额:
    $ 39.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-05 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Deficits in motivation and effort (i.e., avolition) are defining characteristics of several psychiatric and neurological disorders; have adverse effects on functional recovery, disease chronicity, and morbidity; and lack effective treatments. Research and development of novel treatments for avolition has been hindered by the lack of well-validated functional measures of target engagement that are similar across human and non-human model species, possibly due to the use of different approaches in laboratory animals and humans that lack translation. Importantly, neurophysiological recordings enable direct observation of synchronized neural activity with high (ms) temporal resolution and are argued to have higher validity for cross-species comparison of the effects of drugs on behavior compared to cellular or molecular measures. In this regard, and in line with RFA- MH-19-235 and the NIMH RDoC initiative, the current application proposes to optimize, evaluate, and mechanistically test neurophysiological and behavioral assays of physical and cognitive effort in a manner that will enable preclinical pipelines to develop novel and efficacious treatments for avolition in clinical populations In Aim 1, we will optimize rodent behavioral assessments of physical and cognitive effort using the physical effort task (PET) task and cognitive effort task (CET), respectively. Combined behavioral and electrophysiological evaluation will determine the neural substrates of physical and cognitive effortful decision making. In Aim 2, we will validate these models using pharmacological challenges (modafinil and tolcapone) to potentiate the behavioral and neurophysiological correlates of effortful decision making. Finally, in Aim 3, we will investigate the mesostriatal and mesocortical mechanisms underlying drug-induced potentiation of effortful decision making using a combination of optogenetic manipulations in genetically defined neurons, electrophysiological recording, and behavioral pharmacology. Collectively, this application will delineate the precise contributions of mesolimbic and mesocortical dopamine circuits in the mediation of different forms of effortful behavior, identifying neural substrates that can be targeted to ameliorate impairments in motivation that are core to several psychiatric and neurological disorders.
项目总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Probabilistic Reinforcement Learning and Anhedonia.
  • DOI:
    10.1007/7854_2022_349
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Brian D. Kangas;A. Der-Avakian;D. Pizzagalli
  • 通讯作者:
    Brian D. Kangas;A. Der-Avakian;D. Pizzagalli
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRE DER-AVAKIAN其他文献

ANDRE DER-AVAKIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRE DER-AVAKIAN', 18)}}的其他基金

PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications
PAASPort:一种基于网络的工具,用于非临床研究质量评估和偏倚风险管理,以促进创新药物的开发
  • 批准号:
    9886100
  • 财政年份:
    2020
  • 资助金额:
    $ 39.17万
  • 项目类别:
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications
PAASPort:一种基于网络的工具,用于非临床研究质量评估和偏倚风险管理,以促进创新药物的开发
  • 批准号:
    10194710
  • 财政年份:
    2020
  • 资助金额:
    $ 39.17万
  • 项目类别:
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications
PAASPort:一种基于网络的工具,用于非临床研究质量评估和偏倚风险管理,以促进创新药物的开发
  • 批准号:
    10217084
  • 财政年份:
    2020
  • 资助金额:
    $ 39.17万
  • 项目类别:
Preclinical neurophysiological and behavioral assays of motivation and effort
动机和努力的临床前神经生理学和行为分析
  • 批准号:
    10196961
  • 财政年份:
    2019
  • 资助金额:
    $ 39.17万
  • 项目类别:
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies
开发 PTSD/AUD 啮齿动物模型:利用基于临床的策略
  • 批准号:
    10237235
  • 财政年份:
    2017
  • 资助金额:
    $ 39.17万
  • 项目类别:
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies
开发 PTSD/AUD 啮齿动物模型:利用基于临床的策略
  • 批准号:
    9756251
  • 财政年份:
    2017
  • 资助金额:
    $ 39.17万
  • 项目类别:
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms
快感缺乏及其潜在神经机制的转化研究
  • 批准号:
    7613553
  • 财政年份:
    2008
  • 资助金额:
    $ 39.17万
  • 项目类别:
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms
快感缺乏及其潜在神经机制的转化研究
  • 批准号:
    7693743
  • 财政年份:
    2008
  • 资助金额:
    $ 39.17万
  • 项目类别:
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms
快感缺乏及其潜在神经机制的转化研究
  • 批准号:
    7922663
  • 财政年份:
    2008
  • 资助金额:
    $ 39.17万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 39.17万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了